Follow
Krystyna Dabrowska
Krystyna Dabrowska
Hirszfeld Institute of Immunology and Experimental Therapy
Verified email at hirszfeld.pl - Homepage
Title
Cited by
Cited by
Year
Bacteriophage penetration in vertebrates
K Dabrowska, K Switała‐Jelen, A Opolski, B Weber‐Dabrowska, A Gorski
Journal of applied microbiology 98 (1), 7-13, 2005
3382005
Interactions between bacteriophage, bacteria, and the mammalian immune system
JD Van Belleghem, K Dąbrowska, M Vaneechoutte, JJ Barr, PL Bollyky
Viruses 11 (1), 10, 2018
3042018
Biotechnological applications of bacteriophages: state of the art
LK Harada, EC Silva, WF Campos, FS Del Fiol, M Vila, K Dąbrowska, ...
Microbiological research 212, 38-58, 2018
2962018
Bacteriophage translocation
A Górski, E Ważna, BW Dąbrowska, K Dąbrowska, K Świtała-Jeleń, ...
FEMS Immunology & Medical Microbiology 46 (3), 313-319, 2006
2722006
Phage as a modulator of immune responses: practical implications for phage therapy
A Górski, R Międzybrodzki, J Borysowski, K Dąbrowska, P Wierzbicki, ...
Advances in virus research 83, 41-71, 2012
2642012
Mammalian Host-Versus-Phage immune response determines phage fate in vivo
K Hodyra-Stefaniak, P Miernikiewicz, J Drapała, M Drab, ...
Scientific reports 5 (1), 1-13, 2015
2522015
Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review
K Dąbrowska
Medicinal research reviews 39 (5), 2000-2025, 2019
2372019
Immunogenicity studies of proteins forming the T4 phage head surface
K Dąbrowska, P Miernikiewicz, A Piotrowicz, K Hodyra, B Owczarek, ...
Journal of virology 88 (21), 12551-12557, 2014
1762014
Phage therapy: combating infections with potential for evolving from merely a treatment for complications to targeting diseases
A Górski, R Międzybrodzki, B Weber-Dąbrowska, W Fortuna, S Letkiewicz, ...
Frontiers in microbiology 7, 1515, 2016
1622016
Oral application of T4 phage induces weak antibody production in the gut and in the blood
J Majewska, W Beta, D Lecion, K Hodyra-Stefaniak, A Kłopot, ...
Viruses 7 (8), 4783-4799, 2015
1562015
Phages and immunomodulation
A Górski, K Dąbrowska, R Międzybrodzki, B Weber-Dąbrowska, ...
Future microbiology 12 (10), 905-914, 2017
1512017
Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies
K Dąbrowska, ST Abedon
Microbiology and Molecular Biology Reviews 83 (4), e00012-19, 2019
1452019
Phage therapy: what have we learned?
A Górski, R Międzybrodzki, M Łobocka, A Głowacka-Rutkowska, ...
Viruses 10 (6), 288, 2018
1302018
Phage therapy efficacy: a review of the last 10 years of preclinical studies
LDR Melo, H Oliveira, DP Pires, K Dabrowska, J Azeredo
Critical reviews in microbiology 46 (1), 78-99, 2020
1282020
Effects of bacteriophages on free radical production and phagocytic functions
A Przerwa, M Zimecki, K Świtała-Jeleń, K Dąbrowska, E Krawczyk, ...
Medical microbiology and immunology 195 (3), 143-150, 2006
1242006
New insights into the possible role of bacteriophages in host defense and disease
A Gorski, K Dabrowska, K Switala-Jeleń, M Nowaczyk, ...
Medical Immunology 2 (1), 1-5, 2003
1162003
Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool
Z Kaźmierczak, A Górski, K Dąbrowska
Viruses 6 (7), 2551-2570, 2014
1152014
Bacteriophages and transplantation tolerance
A Górski, M Kniotek, A Perkowska-Ptasińska, A Mróz, A Przerwa, ...
Transplantation proceedings 38 (1), 331-333, 2006
1082006
T4 phage and its head surface proteins do not stimulate inflammatory mediator production
P Miernikiewicz, K Dąbrowska, A Piotrowicz, B Owczarek, J Wojas-Turek, ...
PLoS One 8 (8), e71036, 2013
1052013
Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes
R Miedzybrodzki, K Switala-Jelen, W Fortuna, B Weber-Dabrowska, ...
Virus research 131 (2), 233-242, 2008
1042008
The system can't perform the operation now. Try again later.
Articles 1–20